miR-372 promotes breast cancer cell proliferation by directly targeting LATS2

Xueyuan Cheng, Junqiang Chen, Zhong Huang

Open source

DOI
10.3892/etm.2018.5761
Published
2018-01-17
Container
Experimental and Therapeutic Medicine
Publisher
Spandidos Publications
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3892/etm.2018.5761,
  title = {miR-372 promotes breast cancer cell proliferation by directly targeting LATS2},
  author = {Xueyuan Cheng and Junqiang Chen and Zhong Huang},
  year = {2018},
  journal = {Experimental and Therapeutic Medicine},
  doi = {10.3892/etm.2018.5761},
  url = {https://doi.org/10.3892/etm.2018.5761}
}

RIS

TY  - JOUR
TI  - miR-372 promotes breast cancer cell proliferation by directly targeting LATS2
AU  - Xueyuan Cheng
AU  - Junqiang Chen
AU  - Zhong Huang
PY  - 2018
JO  - Experimental and Therapeutic Medicine
DO  - 10.3892/etm.2018.5761
UR  - https://doi.org/10.3892/etm.2018.5761
ER  - 

APA

Cheng, X., Chen, J., & Huang, Z. (2018). miR-372 promotes breast cancer cell proliferation by directly targeting LATS2. Experimental and Therapeutic Medicine. https://doi.org/10.3892/etm.2018.5761

Source records